Omeprazole Unknown Status Phase 4 Trials for CDA Type I Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01795794Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC